News-from old website
International BioIron Society, April 14-18.
Intrinsic LifeSciences is attending the International BioIron Society 2013 Meeting in London, UK, April 14-18.
http://www.bioiron.org/default.aspx
Phase I SBIR Award by NIH, March 29, 2013
Intrinsic LifeSciences has received a Phase I SBIR (R43) Award by NIH/NIDDK/NHLBI: “Hepcidin Lateral Flow Device for Prediction of Acute Kidney Injury”
We are developing a portable lateral flow device that can determine urine and plasma hepcidin concentration rapidly and quantitatively for post-cardiopulmonary bypass patients potentially afflicted with acute kidney injury.
Intrinsic LifeSciences will be at the ASN Kidney Week 2012 Meeting in San Diego
Anyone interested in scheduling a meeting with us to discuss present or future hepcidin analysis needs during the conference can contact us at [email protected], or by calling our corporate number: 1-877-457-5888.
We look forward to seeing you in San Diego!
LAST UPDATED ON WEDNESDAY, 26 SEPTEMBER 2012 19:40
Intrinsic LifeSciences is a proud sponsor of the 2012 East2West Iron Club Meeting
This annual one-day meeting brings together researchers from across North America who maintain a special interest in iron metabolism. Intrinsic LifeSciences will be attending this year’s meeting October 25-26, 2012 at UCLA in Los Angeles.
http://www.eastcoastironclub.org/
LAST UPDATED ON WEDNESDAY, 24 OCTOBER 2012 17:42
Intrinsic LifeSciences will be at the 2012 AACC Annual Meeting in Los Angeles
Anyone interested in scheduling a meeting with us to discuss present or future hepcidin analysis needs during the conference can contact us at [email protected], or by calling our corporate number: 1-877-457-5888.
We look forward to seeing you in Los Angeles!
LAST UPDATED ON TUESDAY, 03 JULY 2012 12:45
Intrinsic LifeSciences has moved locations
Intrinsic LifeSciences has moved locations. We are now in STE. 408.
505 Coast Boulevard South La Jolla, CA 92037 STE. 408
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:01
Intrinsic LifeSciences presented at the American Society of Hematology meeting in Orlando
Intrinsic LifeSciences co-authored 7 posters for the 2011 American Society of Hematology meeting in Orlando.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:02
Intrinsic LifeSciences awarded a 48D tax credit for 2009 and 2010 Research & Development investments
Intrinsic LifeSciences received a notification from the Internal Revenue Service of their successful application for a $245,000 tax credit for Research & Development investments in a Qualifying Therapeutic Development Project.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:04
Intrinsic LifeSciences will be at the 2011 BioIron congress in Vancouver
We are looking forward to seeing you in Vancouver.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:03
Intrinsic LifeSciences is awarded an NIH SBIR Phase 2 grant
NIDDK SBIR grant totals ~$1.3 million for two years.
Focused on production of monoclonal antibodies to hepcidin for the development of a sensitive diagnostic assay.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:04
15 Dec-2009
Intrinsic LifeSciences is awarded an NIH SBIR Grant
Instrinsic Life Sciences was just awarded an NIH Small Business Innovation Research Grant. CEO Mark Westerman, Ph.D. announced that the company received $350,000 for the first phase of assay commercialization activities with potential for $1MM over two years for Phase II activities. Additional information on the prestigious SBIR program is available through the National Institute of Health’s website at nih.gov. Southern California’s BIOCOM picked up this exciting story as well:
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:07
31 Mar-2009
Meet us at BioIron 2009 in Porto, Portugal
Dr. Tomas Ganz, Co-founder of ILS, will be inaugurated as the President of the International BioIron Society. His leadership in the BioIron field creates novel insights into iron homeostasis and diseases involving the molecular biology of the iron regulatory hormone hepcidin.
In addition, Mark Westerman, Founder & CEO of ILS will present an update on the development of hepcidin ELISA kits suitable for automation or laboratory use in clinical research and development projects. Visit our poster and meet Drs. Westerman, Ganz, and Nemeth for disucssions of projects and potential collaborative studies.
LAST UPDATED ON THURSDAY, 07 OCTOBER 2010 22:38
10 Feb-2009
The American Journal of Clinical Nutrition Editorial on the hepcidin vs. pro-hepcidin.
American Journal of Clinical Nutrition Editorial
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:09
Intrinsic LifeSciences scientists demonstrate relationship between iron absorption and hepcidin healthy adult women.
Cornell and ILS scientists demonstrate relationship between iron absorption and hepcidin healthy adult women.
Serum hepcidin is significantly associated with ir
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:11
17 Nov-2008
Intrinsic LifeSciences presents recent data at Iron Overload Meeting in MD
Read more
ILS scientists present recent data at NIH sponsored Iron Overload Meetings in Annapolis, MD October 27-28, 2008
Immunoassay for Human Hepcidin in Blood and Urine
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:10
A new blood test for diseases of iron metabolism
An immunoassay for human serum hepcidin at last: Ganz klar
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:25
08 Dec-2008
Ortho-Centocor and Intrinsic LifeSciences present poster on EPO and hepcidin in rheumatoid arthritis patients at the 2008 ASH meetings in San Francisco.
Relationship Between Epoetin Alfa (EPO) Treatment Hepcidin and EPOBlood abstract archive
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:09
Intrinsic LifeSciences and the UCLA David Geffen School of Medicine announce the publication of their jointly developed ELISA assay for hepcidin in the journal Blood.
Intrinsic LifeSciences and the UCLA David Geffen School of Medicine announce the publication of their jointly developed ELISA assay for hepcidin in the journal Blood.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:15
National Anemia Action Council expert reviews and comments on ILS’s recent Blood paper (Ganz et al. 2008).
National Anemia Action Council expert reviews and comments on ILS’s recent Blood paper (Ganz et al. 2008).
The NAAC gave a very positive review of our Blood Paper. Also in the news on this site, AffyMax and Takeda have discontinued their program for use of Hematide in Cancer Induced Anemia and will instead focus on studies of Hematide for CKD.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:26
08 Aug-2008
Research Alert! – Intrinsic LifeSciences and UCLA develop the first blood test to measure key hormone that regulates iron
Read more
UCLA Press Release
LAST UPDATED ON THURSDAY, 07 OCTOBER 2010 22:39
05 Apr-2008
Intrinsic LifeSciences was a sponsor of ASN/APS symposium “Hepcidin Regulation of Iron Transport ” at the FASEB meeting in San Diego.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:17
05 Apr-2008
Intrinsic LifeSciences Offers World’s First Hepcidin Test
Intrinsic Life Sciences is now offering the world’s first immunodiagnostic test (ELISA) for human hepcidin. The test is sensitive yet robust and is suitable for use in human serum and urine samples. We are currently offering the test for “Research and Development” use only but are pursuing regulatory approvals.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:17
Intrinsic LifeSciences Sponsoring National Anemia Action Committee
Intrinsic LifeSciences Sponsoring National Anemia Action Committee
Intrinsic LifeSciences becomes a sponsor for the National Anemia Action Committee. The NAAC is a national organization dedicated to raising awareness with the public and health professionals about anemia.
LAST UPDATED ON SATURDAY, 10 SEPTEMBER 2011 09:16
